Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bluejay DiagnosticsBJDX -16.55%35 PB Ratio is 0.31 as of Jul. 20, 2026, which is 66% below its 10-year median of 0.90. GuruFocus rates BJDX with a GF Score™ of 35/100. Among 786 Medical Devices & Instruments companies, Bluejay Diagnostics ranks better than 95.8% on this metric.
The historical rank and industry rank for Bluejay Diagnostics's PB Ratio or its related term are showing as below:
BJDX'
s PB Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.9 Max: 2.5
Current: 0.3
During the past 7 years, Bluejay Diagnostics's highest PB Ratio was 2.50. The lowest was 0.01. And the median was 0.90.
BJDX's PB Ratio is ranked better than 95.8% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs BJDX: 0.30
During the past 12 months, Bluejay Diagnostics's average Book Value Per Share Growth Rate was -85.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -90.50% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Bluejay Diagnostics was -87.40% per year. The lowest was -90.50% per year. And the median was -88.95% per year.
Back to Basics: PB Ratio
Bluejay Diagnostics (NAS:BJDX) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bluejay Diagnostics PB Ratio Related Terms
Bluejay Diagnostics PB Ratio Historical Data
* Premium members only.
The historical data trend for Bluejay Diagnostics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bluejay Diagnostics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bluejay Diagnostics PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bluejay Diagnostics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bluejay Diagnostics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bluejay Diagnostics (BJDX) has a PB Ratio of 0.31 as of Jul. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bluejay Diagnostics and its competitors. This is 66% below median its historical median of 0.90. Over the past decade, Bluejay Diagnostics' PB Ratio has ranged from 0.01 to 2.50. According to the industry distribution chart, Bluejay Diagnostics ranks #33 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 4.2%.
Is Bluejay Diagnostics' PB Ratio too high?
Bluejay Diagnostics' current PB Ratio of 0.31 is 66% below median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 2.50. The Medical Devices & Instruments industry median PB Ratio is 2.04. Bluejay Diagnostics' value of 0.31 is 84.8% below this industry median. Based on the distribution chart, Bluejay Diagnostics ranks #33 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bluejay Diagnostics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Bluejay Diagnostics' PB Ratio compare to ALURD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Bluejay Diagnostics ranks #33 out of 786 companies for PB Ratio. This places Bluejay Diagnostics in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. Bluejay Diagnostics' value of 0.31 is 84.8% below this benchmark. Historically, Bluejay Diagnostics' own PB Ratio has ranged from 0.01 to 2.50 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 2.04, Bluejay Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bluejay Diagnostics's current PB Ratio of 0.31 is 84.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bluejay Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bluejay Diagnostics's current PB Ratio is 0.31, which is 66% below median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluejay Diagnostics stock overvalued right now?
Bluejay Diagnostics (BJDX) has a current PB Ratio of 0.31. The current PB Ratio is 0.31, which is 66% below median its 10-year median of 0.90 and 84.8% below the Medical Devices & Instruments industry median of 2.04. Bluejay Diagnostics' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bluejay Diagnostics (BJDX), the current PB Ratio is 0.31 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
35GF Score
Get the complete analysis for BJDX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJDX has been successfully added to your 
